Lown-Ganong-Levine syndrome

Lown-Ganong-Levine Syndrome (LGL) is a rare cardiac arrhythmia disorder characterized by a short PR interval on an electrocardiogram (ECG) without the presence of a Wolff-Parkinson-White (WPW) pattern. It is named after Bernard Lown, Samuel A. Levine, and William Ganong, who first described the syndrome in 1952. LGL syndrome is considered a form of pre-excitation syndrome, where the heart's electrical signals travel faster than normal from the atria to the ventricles.

Symptoms and Diagnosis

Patients with Lown-Ganong-Levine syndrome may be asymptomatic or present with symptoms related to supraventricular tachycardia (SVT), such as palpitations, dizziness, fainting, or rarely, cardiac arrest. The diagnosis of LGL syndrome is primarily based on the ECG findings of a short PR interval (<120 ms) and the absence of a delta wave, which distinguishes it from WPW syndrome. Additional diagnostic tests, including electrophysiological study (EPS), may be performed to further evaluate the electrical pathways within the heart.

Pathophysiology

The pathophysiology of Lown-Ganong-Levine syndrome involves an accessory electrical pathway between the atria and the ventricles, known as the James fiber. Unlike the accessory pathway in WPW syndrome, which conducts electrical signals around the normal conduction system, the James fiber directly connects the atria and the ventricles, bypassing the atrioventricular node (AV node). This results in the rapid transmission of electrical impulses from the atria to the ventricles, leading to the short PR interval observed in LGL syndrome.

Treatment

The management of Lown-Ganong-Levine syndrome focuses on controlling symptoms and preventing complications associated with supraventricular tachycardia. Treatment options may include pharmacological agents such as beta blockers, calcium channel blockers, or antiarrhythmic drugs. In some cases, particularly when medication is ineffective or not tolerated, catheter ablation may be considered to disrupt the abnormal electrical pathway and restore normal heart rhythm.

Prognosis

The prognosis for individuals with Lown-Ganong-Levine syndrome is generally good, especially when the condition is effectively managed with medication or catheter ablation. However, patients are at an increased risk for developing supraventricular tachycardias and should be monitored regularly for changes in symptoms or heart rhythm.

Epidemiology

Lown-Ganong-Levine syndrome is a rare condition, and its exact prevalence is unknown. It can occur in individuals of any age but is most commonly diagnosed in young adults.

See Also

• Cardiac electrophysiology
• Electrocardiography
• Pre-excitation syndrome
• Wolff-Parkinson-White syndrome

Cardiovascular disease A-Z

Most common cardiac diseases

• Cardiac arrhythmia‎
• Cardiogenetic disorders‎
• Cardiomegaly‎
• Cardiomyopathy‎
• Cardiopulmonary resuscitation‎
• Chronic rheumatic heart diseases‎
• Congenital heart defects‎
• Heart neoplasia‎
• Ischemic heart diseases‎
• Pericardial disorders
• Syndromes affecting the heart‎
• Valvular heart disease‎

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

• Accelerated idioventricular rhythm
• Acute decompensated heart failure
• Arteriosclerotic heart disease
• Athletic heart syndrome
• Atrial flutter
• Atrioventricular fistula
• Cardiovascular disease in Australia
• Autoimmune heart disease

B

• Brown atrophy of the heart

C

• Ebb Cade
• Cardiac allograft vasculopathy
• Cardiac amyloidosis
• Cardiac asthma
• Cardiac tamponade
• Cardiogenic shock
• Cardiogeriatrics
• Cardiorenal syndrome
• Cardiotoxicity
• Carditis
• Coronary artery aneurysm
• Coronary artery anomaly
• Coronary artery disease
• Spontaneous coronary artery dissection
• Coronary artery ectasia
• Coronary occlusion
• Coronary steal
• Coronary thrombosis
• Coronary vasospasm
• Cœur en sabot
• Coxsackievirus-induced cardiomyopathy

D

• Duke Treadmill Score
• Duroziez's disease

E

• Eisenmenger's syndrome
• Embryocardia
• Endocardial fibroelastosis
• Eosinophilic myocarditis

H

• Heart attack
• Heart failure
• Heart failure with preserved ejection fraction
• Heart to Heart (1949 film)
• High-output heart failure
• Hyperdynamic precordium

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

• Idiopathic giant-cell myocarditis
• Interventricular dyssynchrony
• Intraventricular dyssynchrony
• Isolated atrial amyloidosis

K

• Keshan disease

L

• Loeffler endocarditis

M

• Mydicar
• Myocardial bridge
• Myocardial disarray
• Myocardial rupture
• Myocardial scarring
• Myocardial stunning
• Myocarditis

N

• Nonbacterial thrombotic endocarditis

O

• OLR1
• Ostial disease

P

• Papillary fibroelastoma
• Pathophysiology of heart failure
• Postpericardiotomy syndrome
• Pulmonary vein stenosis

R

• Right axis deviation
• Roemheld syndrome

S

• Saturated fat and cardiovascular disease
• SCAR-Fc
• Shone's syndrome
• Strain pattern
• Subacute bacterial endocarditis
• Sudden cardiac death of athletes

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T

• Traumatic cardiac arrest

V

• Ventricular aneurysm
• Vibroacoustic disease
• Viral cardiomyopathy

W

• Waon therapy